Dosimetry Estimate (OLINDA)
Site | 68Ga-FAPI-2 | 68Ga-FAPI-4 |
Adrenals | 1.23E−02 | 1.12E−02 |
Brain | 9.54E−03 | 9.11E−03 |
Breasts | 9.58E−03 | 8.88E−03 |
Gallbladder wall | 1.19E−02 | 1.13E−02 |
Lower large intestine wall | 1.23E−02 | 1.17E−02 |
Small intestine | 1.19E−02 | 1.13E−02 |
Stomach wall | 1.13E−02 | 1.06E−02 |
Upper large intestine wall | 1.17E−02 | 1.11E−02 |
Heart wall | 4.73E−02 | 2.02E−02 |
Kidneys | 4.45E−02 | 4.43E−02 |
Liver | 1.51E−02 | 1.46E−02 |
Lungs | 1.09E−02 | 9.89E−03 |
Muscle | 1.04E−02 | 9.91E−03 |
Ovaries | 1.24E−02 | 1.19E−02 |
Pancreas | 1.23E−02 | 1.13E−02 |
Red marrow | 3.28E−02 | 2.08E−02 |
Osteogenic cells | 2.94E−02 | 2.16E−02 |
Skin | 9.01E−03 | 8.63E−03 |
Spleen | 2.62E−02 | 1.05E−02 |
Testes | 1.04E−02 | 1.01E−02 |
Thymus | 1.15E−02 | 1.01E−02 |
Thyroid | 1.03E−02 | 9.82E−03 |
Urinary bladder wall | 8.89E−02 | 9.91E−02 |
Uterus | 1.33E−02 | 1.30E−02 |
Total body | 1.19E−02 | 1.09E−02 |
Effective dose (mSv/MBq) | 1.80E−02 | 1.64E−02 |